Digital Health: Page 16
-
Getty Images
Sponsored by OptimizeRxTurning your unique brand knowledge into stronger HCP relationships
How life science companies can translate their extensive brand knowledge into a digital, forward-looking HCP engagement strategy.
July 25, 2022 -
Getty Images
Johns Hopkins sepsis alert tool reduced patient deaths, studies find
Three prospective studies of a machine learning tool developed by a Johns Hopkins spinout found it led to earlier antibiotic treatment and reduced patient mortality.
By Elise Reuter • July 22, 2022 -
Getty Images
FDA patient advisers grapple with consent, oversight of virtual-reality devices in healthcare
The advisory group addressed patient consent in surgeries using augmented reality tools and how to distinguish clinical uses of virtual reality from entertainment products.
By Elise Reuter • July 20, 2022 -
Permission granted by iRhythm Technologies
iRhythm says Q2 unit volumes beat forecast, names Chad Patterson as new CCO
The company noted the results are preliminary and may change before its Aug. 4 earnings call.
By Ricky Zipp • July 19, 2022 -
Permission granted by DarioHealth
Lack of payment pathway clarity hinders digital therapeutics, analysts say
The report warns of a sector beset by payment issues, “snake oil” and “middling adoption.”
By Nick Paul Taylor • July 15, 2022 -
Permission granted by iRhythm Technologies
CMS proposes national rates for cardiac monitoring; iRhythm's stock jumps
The proposed rule could end a years-long saga for the cardiac market, although pricing specifics may change in the final version.
By Ricky Zipp • July 8, 2022 -
Getty Images
Semiconductor shortage leaves medtech industry 'more pessimistic' as customers leave, says Deloitte
Hospitals and health systems are looking into alternative products as a result of the disruption, according to a report from Deloitte and AdvaMed.
By Nick Paul Taylor • July 7, 2022 -
Courtesy of Fitbit
Wearables are a growing part of doctor-patient talks for cardiac patients: study
As mentions of wearables in primary care grew, Apple increasingly replaced Fitbit as the most-discussed wearable brand in talks between physicians and patients in the study, which covered the years 2005 to 2019.
By Nick Paul Taylor • July 6, 2022 -
(Photo by Dan Kitwood/Getty Images) via Getty Images
'Little sign' that digital tools are being deployed effectively in fight against COVID outbreak, study finds
To help reduce the spread of the next pandemic, there is “a substantial practical advantage” to integrating the features of multiple smartphone apps, a Scripps Research Translational Institute team found.
By Nick Paul Taylor • July 6, 2022 -
Permission granted by Apple
AliveCor ECG patent ruling sets stage for block on Apple Watch imports
Apple Watch imports to the U.S. could be barred if ruling by International Trade Court judge is finalized; Judge says Apple Watch infringes two cardiogram patents.
By Nick Paul Taylor • July 5, 2022 -
Retrieved from LiveMetric website on July 01, 2022
LiveMetric's blood-pressure 'smartwatch' device gets FDA clearance
The wristwatch-like device will be made available through health systems, insurers and self-insured employers to ease continuous monitoring of blood pressure and avoid white-coat syndrome.
By Nick Paul Taylor • July 1, 2022 -
Getty Images
Medtech M&A falls 85% but activity could rebound in second half: report
PwC highlights a range of barriers that could stop acquisitions, including supply chain issues, scrutiny from the Federal Trade Commission and geopolitical concerns.
By Nick Paul Taylor • June 24, 2022 -
Megan Quinn/MedTech Dive
Deep DiveAs cross-state telemedicine waivers expire, virtual care advocates focus on long-term policy changes
There’s a complication: No one solution to the U.S.’ patchy physician licensing infrastructure has universal buy-in.
By Rebecca Pifer Parduhn • June 22, 2022 -
Getty Images
Lack of clinical evidence 'major gap' in digital health: study
The researchers framed the low scores as evidence of “a major gap in health care technology,” adding that there is a “significant opportunity” for companies that differentiate themselves with a more rigorous approach.
By Nick Paul Taylor • June 22, 2022 -
Carl Court via Getty Images
Senseonics lands CE mark for 6-month CGM implant, teeing up Q3 launch in Europe
Senseonics is looking to the longer-lasting implant to re-energize its fight in a market dominated by Abbott Laboratories and Dexcom.
By Nick Paul Taylor • June 17, 2022 -
Permission granted by Apple
Apple Watch monitoring features for AFib, Parkinson's cleared by FDA
With the new feature, atrial fibrillation patients may have an easier way to track the frequency of the condition over time and see whether lifestyle changes may have positive effects.
By Nick Paul Taylor • June 14, 2022 -
Insulet Omnipod 5 release
Insulet targets competitive conversions as Omnipod 5 insulin pump nears full launch
The company said at a conference it aims to increase the rate of insulin pump use among people with Type 1 diabetes in the U.S.
By Nick Paul Taylor • June 9, 2022 -
Permission granted by Dexcom
Q&ADexcom CEO Sayer on G7 FDA submission, developing a 15-day sensor, M&A plans
Kevin Sayer spoke about the company's back-and-forth with the FDA on the G7 CGM system, possibly expanding from a 10-day to a 15-day sensor and on a report that Dexcom was in talks to buy Insulet.
By Ricky Zipp • June 7, 2022 -
Permission granted by Pear Therapeutics
Pear sets out payer strategy as it seeks to quadruple prescriptions of digital therapeutics
Pear shared real-world data that linked its digital therapeutic for substance use disorder to an estimated $3,591 reduction in per-patient costs.
By Nick Paul Taylor • June 7, 2022 -
Verily advances smartwatch toward Parkinson's clinical trial use after validating technology
The researchers concluded the wearable device could reduce the sample size needed to show the effect of a therapeutic intervention.
By Nick Paul Taylor • May 25, 2022 -
How a Dexcom-Insulet combination would shake up the diabetes treatment industry
Following a Bloomberg News report that Dexcom is in talks to buy Insulet, analysts say such a move would put competitors in a "tough spot."
By Ricky Zipp • May 25, 2022 -
Courtesy of Dexcom, Nick Jonas Super Bowl kit
Dexcom says it's not in acquisition talks
Bloomberg News reported last week that the company was seeking to buy Insulet.
By Ricky Zipp • Updated May 31, 2022 -
Permission granted by OptimizeRx
Sponsored by OptimizeRxAI and RWD in HCP engagement – here's the secret to effective execution
Rethink your approach to AI and RWD and turn ideas into actionable strategies for medtech marketers.
May 23, 2022 -
David Paul Morris via Getty Images
Google hires former FDA digital health officer to global strategy post
In his new role, Bakul Patel will help Google build a unified digital health and regulatory strategy.
By Samantha Liss • May 19, 2022 -
Permission granted by Pear Therapeutics
Pear more than doubles revenue from last quarter, shares new economic data
The company is keeping its 2022 revenue forecast of $22 million. Pear also presented economic data, which analysts said would be important in conversations with payers.
By Elise Reuter • May 17, 2022
Previous
